New targeted treatments for non-small-cell lung cancer – role of nivolumab
Giulia Zago,1,2,* Mirte Muller,1,* Michel van den Heuvel,1 Paul Baas1 1Department of Thoracic Oncology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek (NKI-AvL), Amsterdam, the Netherlands; 2Medical Oncology 2, Istituto Oncologico Veneto (IOV), Padova, Italy *These authors contributed equa...
Enregistré dans:
Auteurs principaux: | Zago G, Muller M, van den Heuvel M, Baas P |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2016
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/351457bbde574736917aee73bafcbb1c |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Effect of antibiotic use on the efficacy of nivolumab in the treatment of advanced/metastatic non-small cell lung cancer: A meta-analysis
par: Huo Geng-wei, et autres
Publié: (2021) -
New PD-L1 inhibitors in non-small cell lung cancer – impact of atezolizumab
par: Seetharamu N, et autres
Publié: (2017) -
Use of nivolumab for colon cancer with Lynch syndrome
par: G. A. Khakimov, et autres
Publié: (2020) -
Dual immunological blockade in the treatment of metastatic non-small cell lung cancer: reality and perspectives
par: Denis I. Yudin, et autres
Publié: (2021) -
Immunotherapeutic Advances for NSCLC
par: Massafra M, et autres
Publié: (2021)